NTHL1 and breast carcinoma: Therefore, we speculate that in different molecular subtypes of breast cancers, the differential methylation status of NTHL1 should be associated with its differential expression and could represent a substantial epigenetic modification pattern [42], thereby validating the efficacy and accuracy of our prediction.